---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-025653"
form_type: "8-K"
ticker: "MLSS"
cik: "0000855683"
company_name: "MILESTONE SCIENTIFIC INC."
filed_at: "2023-09-12T23:59:59+00:00"
generated_at: "2026-06-10T21:32:48.581837+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Milestone Scientific appoints Dr. Didier Demesmin as independent director

## Summary
- Appointed September 6, 2023 as independent director by unanimous board vote.
- Dr. Demesmin is CEO/Medical Director of University Pain Medicine Center since 2007.
- Director of Pain Management at St. Peter's University Hospital since 2006.
- Holds clinical faculty positions at Rutgers RWJ Medical School and several hospital pain medicine departments.
- Earned MD from UMDNJ and MBA from Northwestern Kellogg in 2018.

## SEC filing metadata
- accession: 0001437749-23-025653
- form_type: 8-K
- ticker: MLSS
- cik: 0000855683
- company_name: MILESTONE SCIENTIFIC INC.
- filed_at: 2023-09-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/855683/000143774923025653/0001437749-23-025653-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/855683/000143774923025653/mlss20230911_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-025653
- JSON: https://secwatch.observer/filing/0001437749-23-025653.json
- Plain text: https://secwatch.observer/filing/0001437749-23-025653.txt

## Key facts
- Executive change
  Dr. Didier Demesmin was appointed as independent director at MILESTONE SCIENTIFIC INC..
  - Action: appointed
  - Role: independent director
  source text: On September 6, 2023, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Dr. Didier Demesmin as an independent director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/855683/000143774923025653/0001437749-23-025653-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.